Evidence map›Paper›PMID 26730361›Full record

ReviewChonnam medical journal2015

Predictive Efficacy of Interim Positron Emission Tomography/Computed Tomography (PET/CT) for the Treatment of Aggressive Lymphoma.

Deok-Hwan Yang, Sung-Hoon Jung, Jae-Sook Ahn, Yeo-Kyeoung Kim, Jung-Joon Min, Hee-Seung Bom, Je-Jung Lee, Hyeoung-Joon Kim

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Chonnam medical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Score-Based Approach toDiagnostics (Basel, Switzerland) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Deok-Hwan YangDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Sung-Hoon JungDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Jae-Sook AhnDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Yeo-Kyeoung KimDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Jung-Joon MinInstitute for Molecular Photonic Imaging Research, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Hee-Seung BomInstitute for Molecular Photonic Imaging Research, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Je-Jung LeeDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.
Hyeoung-Joon KimDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic value of whole-body positron emission tomography/computed tomography (PET/CT) with (18)F-fluoro-2-deoxy-D-glucose (FDG) shortly after the onset of induction chemotherapy or mid treatment could help to predict long-term clinical outcomes in patients with Hodgkin's or Non-Hodgkin's lymphoma. However, FDG is not a tumor-specific substance, and it may accumulate to the point of being detected in a variety of benign conditions or at physiologic anatomical sites, which may give rise to false-positive interpretation. In an attempt to standardize the reporting criteria for interim PET/CT, the First International Workshop on Interim PET in Lymphoma suggested visual response criteria with the Deauville five-point scale, and the standardized uptake value (SUV) has been investigated in comparison with this visual system. A quantitative approach using the measurement of maximal SUV (SUVmax) or the reduction rate of SUVmax (ΔSUVmax) might be more appropriate in early-response PET/CT for reducing false-positive rates or for decreasing interobserver variability in interpretation. In this review, the predictive efficacy of PET/CT is discussed for the treatment of aggressive lymphoma, especially in terms of an interim PET/CT-based prognostic model.

Indexed as

LymphomaNon-HodgkinPositron-emission tomographyPrognosis

Identifiers

PMID26730361
PMCPMC4697110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.